STOCK TITAN

Glaukos COO Joseph E. Gilliam sells 861 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Glaukos Corp. (GKOS) President & COO Joseph E. Gilliam exercised options covering 861 shares on November 16, 2026, at exercise prices of $48.46, $55.18 and $69.30 per share, and sold 861 common shares at $250 per share. The option exercises and sale were made under a Rule 10b5-1 trading plan adopted August 13, 2026.

Insider Gilliam Joseph E
Role PRESIDENT & COO
Sold 861 shs ($215K)
Approx. gross sale proceeds $215K
Approx. exercise cost $47K
Approx. pre-tax spread $169K
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F3, F4 82 $0.00 $0.00
Exercise Stock Option (Right to Buy) F3, F4 100 $0.00 $0.00
Exercise Stock Option (Right to Buy) F3, F5 200 $0.00 $0.00
Exercise Stock Option (Right to Buy) F3, F6, F7 200 $0.00 $0.00
Exercise Stock Option (Right to Buy) F3, F8 279 $0.00 $0.00
Exercise Common Stock F1 82 $69.30 $6K
Exercise Common Stock F1 100 $48.46 $5K
Exercise Common Stock F1 200 $55.18 $11K
Exercise Common Stock F1 279 $55.18 $15K
Exercise Common Stock F1 200 $48.46 $10K
Sale Common Stock F2, F1 861 $250.00 $215K
Holdings After Transaction: Stock Option (Right to Buy) — 95,617 options (Direct); Common Stock — 71,602 shares (Direct)
Footnotes (8)
  1. F1. Includes 40,039 restricted stock units that have not yet vested or been delivered to the Reporting Person.
  2. F2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2026.
  3. F3. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2026.
  4. F4. These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
  5. F5. Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
  6. F6. Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals.
  7. F7. Amount reported has been adjusted to reflect a mathematical error contained in the Form 4 filed with the SEC on November 16, 2026.
  8. F8. Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
Options exercised 861 shares November 16, 2026
Shares sold 861 shares November 16, 2026
Sale price $250 per share November 16, 2026
Option exercise price $48.46 per share Option exercises on November 16, 2026
Option exercise price $55.18 per share Option exercises on November 16, 2026
Option exercise price $69.30 per share Option exercises on November 16, 2026
Rule 10b5-1 trading plan financial
"pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
restricted stock units financial
"Includes 40,039 restricted stock units that have not yet vested"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GKOS shares did Joseph E. Gilliam sell, and at what price?

Joseph E. Gilliam sold 861 common shares at $250 per share on November 16, 2026.

What were Joseph E. Gilliam's GKOS option exercise prices?

He exercised options at $48.46, $55.18 and $69.30 per share on November 16, 2026.

Were Joseph E. Gilliam's GKOS option exercises and sale under a trading plan?

Yes. Both were made under a Rule 10b5-1 trading plan adopted August 13, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gilliam Joseph E

(Last)(First)(Middle)
C/O GLAUKOS CORPORATION
ONE GLAUKOS WAY

(Street)
ALISO VIEJO CALIFORNIA 92656

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GLAUKOS Corp [ GKOS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
PRESIDENT & COO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/16/2026M82A$69.371,684(1)D
Common Stock11/16/2026M100A$48.4671,784(1)D
Common Stock11/16/2026M200A$55.1871,984(1)D
Common Stock11/16/2026M279A$55.1872,263(1)D
Common Stock11/16/2026M200A$48.4672,463(1)D
Common Stock11/16/2026S(2)861D$25071,602(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$69.311/16/2026M82(3) (4)03/14/2029Common Stock82$0743D
Stock Option (Right to Buy)$48.4611/16/2026M100(3) (4)03/22/2033Common Stock100$019,151D
Stock Option (Right to Buy)$48.4611/16/2026M200(3) (5)03/22/2033Common Stock200$019,051D
Stock Option (Right to Buy)$55.1811/16/2026M200(3) (6)03/24/2032Common Stock200$021,668(7)D
Stock Option (Right to Buy)$55.1811/16/2026M279(3) (8)03/24/2032Common Stock279$035,004D
Explanation of Responses:
1. Includes 40,039 restricted stock units that have not yet vested or been delivered to the Reporting Person.
2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2026.
3. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2026.
4. These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
5. Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
6. Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals.
7. Amount reported has been adjusted to reflect a mathematical error contained in the Form 4 filed with the SEC on November 16, 2026.
8. Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
Diana Scherer, Attorney-in-Fact11/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading